Sukeshi Arora MD (@drsukeshiarora) 's Twitter Profile
Sukeshi Arora MD

@drsukeshiarora

Yogi, medical oncologist caring for patients with GI cancers, she/her. Views are my own. Have a blessed day! @UTHealthSAMDA #GIcancers
insta: @yogaoncology

ID: 1156975789927256065

calendar_today01-08-2019 17:11:38

3,3K Tweet

935 Followers

612 Following

Neil Newman (@nbn426) 's Twitter Profile Photo

Such a pleasure to see my friends - my current resident and my former med student as finalists 👏🏼👏🏼👏🏼

ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

📣 ESMO Living Guideline on Hepatocellular Carcinoma: 👉 New title with the latest recommendations and algorithms in an interactive format. #ClinicalPracticeGuideline Arndt Vogel 🔗 ow.ly/CHpJ50VHbYg

📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
#ClinicalPracticeGuideline <a href="/ArndtVogel/">Arndt Vogel</a>
🔗 ow.ly/CHpJ50VHbYg
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

🤠 👉🏽 🗽 news: I will be joining NYU Langone Health on September 1, 2025 as Director of the GI Cancer Center & Associate Director of Translational Research at Perlmutter Cancer Center at NYU Langone Health. I am excited to start the next chapter of the Maitra Lab in NYC & build a strong GI cancer research program.

Fight Colorectal Cancer (@fightcrc) 's Twitter Profile Photo

At Fight CRC, we’re dedicated to advancing health equity and raising awareness about disparities in cancer care. Hispanic/Latino individuals are more likely to be diagnosed with colorectal cancer at a later stage—putting them at higher risk for worse outcomes. We’re working to

At Fight CRC, we’re dedicated to advancing health equity and raising awareness about disparities in cancer care.

Hispanic/Latino individuals are more likely to be diagnosed with colorectal cancer at a later stage—putting them at higher risk for worse outcomes. We’re working to
OncLive.com (@onclive) 's Twitter Profile Photo

Thank you to Dr Deepak Vadehra, of @roswellpark, who joined us at #AACR25 to discuss metabolic profiles in early-onset CRC! See our site for more meeting insights! Deepak Vadehra AACR #crcsm #oncology onclive.com/conference/aacr

Thank you to Dr Deepak Vadehra, of @roswellpark, who joined us at #AACR25 to discuss metabolic profiles in early-onset CRC! See our site for more meeting insights! <a href="/Deebacca/">Deepak Vadehra</a> <a href="/AACR/">AACR</a> #crcsm #oncology 
onclive.com/conference/aacr
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Mic-drop presentation at AACR by Cercek et al Non-operative management of MSI-H tumors showing outstanding responses to single agent IO across tumor types. 117 patients with MSI-H tumors 92% RFS at 2 years 35% of patients without ANY adverse events Option for curative intent

Mic-drop presentation at AACR by Cercek et al 

Non-operative management of MSI-H tumors showing outstanding responses to single agent IO across tumor types.

117 patients with MSI-H tumors
92% RFS at 2 years
35% of patients without ANY adverse events
Option for curative intent
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available. JAMA Oncology OncoAlert Oncology Brothers LARVOL jamanetwork.com/journals/jamao…

A simple move, a big impact:
Giving IV magnesium before cisplatin cut kidney injury risk by 20%!
Safe. Cheap. Available.
<a href="/JAMAOnc/">JAMA Oncology</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/OncBrothers/">Oncology Brothers</a> <a href="/Larvol/">LARVOL</a> 
jamanetwork.com/journals/jamao…
Sukeshi Arora MD (@drsukeshiarora) 's Twitter Profile Photo

Thank you Dr. Cathy Eng for your support throughout! You are an admiration for so many women in medicine, esp in GI onc, esp for WOC. I aspire to learn from your mentorship and sponsorship.

Heloisa Soares MD (@helops79) 's Twitter Profile Photo

Big news for the #NETs community! ASCO has released its first guideline to help oncologists manage symptoms of GEP NETS. A major step forward in improving quality of life of patients. dailynews.ascopubs.org/do/asco-releas… congrats Jaydira Del Rivero, MD and all!

Diego A. Díaz García (@diegoadiazg) 's Twitter Profile Photo

🧬 Organ preservation in early-stage dMMR tumors? Neoadjuvant PD-1 blockade with dostarlimab led to clinical complete response in 80% of patients, most avoided surgery. ✅ 2-yr recurrence-free survival: 92%. A paradigm shift? 📖 NEJM 🔗 doi.org/10.1056/NEJMoa… #oncology

🧬 Organ preservation in early-stage dMMR tumors?

Neoadjuvant PD-1 blockade with dostarlimab led to clinical complete response in 80% of patients, most avoided surgery. 
✅ 2-yr recurrence-free survival: 92%. 

A paradigm shift?

📖 <a href="/NEJM/">NEJM</a> 
🔗 doi.org/10.1056/NEJMoa…
#oncology
Young SIOG (@youngsiog) 's Twitter Profile Photo

📢 Calling all Young SIOGers! We’re launching a new article series in the Journal of Geriatric Oncology What oncologists need to know about… major geriatric syndromes First topic: Dementia / Cognitive Impairment 🧵👇

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

PANOVA-3: gem/abraxane +/- TTF in locally advanced pancreas cancer. #ASCO25 As compared to other approved LAPC therapies, numerical benefit to TTF is non-trivial (2 month OS, improvement in pain free interval 9 to 15 months), & cost/toxicity less than many. But… 1/3

PANOVA-3: gem/abraxane +/- TTF in locally advanced pancreas cancer. #ASCO25

As compared to other approved LAPC therapies, numerical benefit to TTF is non-trivial (2 month OS, improvement in pain free interval 9 to 15 months), &amp; cost/toxicity less than many.

But…

1/3